Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy

Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy

Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer therapy that targets cancer cells using a monoclonal antibody-photon absorber conjugate (APC) that is bound to the target cell surface. Subsequent application of low levels of NIR light results in immediate cancer cell death. The...

Full description

Bibliographic Details
Main Authors: Hideyuki Furumoto, Ryuhei Okada, Takuya Kato, Hiroaki Wakiyama, Fuyuki Inagaki, Hiroshi Fukushima, Shuhei Okuyama, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
near-infrared photoimmunotherapy
light dose
EGFR
side effects
Online Access:https://www.mdpi.com/2072-6694/14/16/4042

Internet

https://www.mdpi.com/2072-6694/14/16/4042

Similar Items